HB 172
relative to investigating potential redundancies between the prescription drug affordability board and existing state agency programs regarding prescription drug cost data.
Status: Killed
This page draws the record — sponsors, votes, hearings, committee reports and the bill text — in the browser, so it needs JavaScript. Everything it shows comes from the files linked below, which need none.
All bills